Veradigm Inc. (NASDAQ:MDRX – Get Free Report)’s share price gapped down before the market opened on Monday . The stock had previously closed at $9.50, but opened at $9.25. Veradigm shares last traded at $9.50, with a volume of 63,337 shares traded.
Wall Street Analysts Forecast Growth
Separately, StockNews.com started coverage on Veradigm in a research report on Thursday. They issued a “hold” rating for the company. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $11.75.
Get Our Latest Analysis on Veradigm
Veradigm Price Performance
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC bought a new position in Veradigm Inc. (NASDAQ:MDRX – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Read More
- Five stocks we like better than Veradigm
- What is the Nikkei 225 index?
- Dow Jones: A Relevant Benchmark or a Relic of the Past?
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- Do ETFs Pay Dividends? What You Need to Know
- Time to Board Carnival Cruise Lines’ Stock Price Rally
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.